VIRGINIA LAW PORTAL

• Code of Virginia
• Virginia Administrative Code
• Constitution of Virginia
• Charters
• Authorities
• Compacts
• Uncodified Acts
• RIS Users (account required)

SEARCHABLE DATABASES

• Bills & Resolutions
  session legislation
• Bill Summaries
  session summaries
• Reports to the General Assembly
  House and Senate documents
• Legislative Liaisons
  State agency contacts

ACROSS SESSIONS

• Subject Index: Since 1995
• Bills & Resolutions: Since 1994
• Summaries: Since 1994

Developed and maintained by the Division of Legislative Automated Systems.

2023 SESSION

• | print version

HB 2233 Prescription drug price transparency; manufacturer reporting requirements.

Introduced by: Mark D. Sickles | all patrons    ...    notes | add to my profiles

SUMMARY AS INTRODUCED:

Prescription drug price transparency; manufacturer reporting requirements. Removes the requirement that a drug manufacturer submit to the Department of Health's contracted nonprofit data services organization all information included in the manufacturer's annual consolidation report on Securities and Exchange Commission Form 10-K or any other public disclosure in order for the manufacturer's prescription drug reporting obligations to be fully satisfied.

FULL TEXT

• 01/11/23  House: Prefiled and ordered printed; offered 01/11/23 23102980D  pdf | impact statement

HISTORY

• 01/11/23  House: Prefiled and ordered printed; offered 01/11/23 23102980D
• 01/11/23  House: Referred to Committee on Commerce and Energy
• 01/30/23  House: Assigned sub: Subcommittee #4
• 02/07/23  House: Left in Commerce and Energy